Fundraising Fox
Mesenbio
3 known investors
Find your way into Mesenbio
Each arrow is one introduction. Sign up to fill in the first one.
Ask Chris Yeowart to introduce you to Anita Adams
You →Chris · together at Poptop.uk.com - Event Planning Concierge Service →Anita
Sign up to find every way you can get introduced to Mesenbio
- Your email: who you already know at Mesenbio, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Mesenbio team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Mesenbio develops extracellular vesicle (EV) therapeutics derived from mesenchymal stem cells, using its FT-01 platform to enable scalable, GMP-ready EV manufacturing for regenerative medicine. The company is advancing a licensing-ready production platform and preclinical therapeutic candidate (MEV-N01) targeting rheumatoid arthritis.
Founders & leadership
Board
Investors · 3
How we know: DSW Ventures's portfolio page · funding news · setsquared.co.uk · Not right? Tell us
How we know: funding news · Not right? Tell us
Also in the syndicate · 1
In the news
Frequently asked questions
- What does Mesenbio do?
- Mesenbio develops extracellular vesicle (EV) therapeutics derived from mesenchymal stem cells, using its FT-01 platform to enable scalable, GMP-ready EV manufacturing for regenerative medicine. The company is advancing a licensing-ready production platform and preclinical therapeutic candidate (MEV-N01) targeting rheumatoid arthritis.
- Who are Mesenbio's investors?
- Mesenbio's investors include DSW Ventures, Innovate UK.